New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors
- PMID: 19124221
- DOI: 10.1016/j.jclinepi.2008.06.014
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors
Abstract
Objective: The magnitude of the benefit of influenza vaccine among elderly individuals has been recently debated. Existing vaccine effectiveness estimates derive primarily from observational studies, which may be biased. In this paper, we provide a methodological examination of the potential sources of bias in observational studies of influenza vaccine effectiveness in seniors and propose design and analysis strategies to reduce bias in future studies.
Study design and setting: We draw parallels to bias documented in observational studies of therapies in other areas of medical research including pharmacoepidemiology, discuss reasons why existing adjustment methods in influenza studies may not adequately control for the bias, and evaluate statistical approaches that may yield more accurate estimation of influenza vaccine effectiveness.
Results: There is strong evidence for the presence of bias in existing observational estimates of influenza vaccine effectiveness in the elderly and the failure of current adjustment methods to reduce bias.
Conclusion: Promising approaches for reducing bias include obtaining more accurate information on confounders, such as functional status, avoiding all-cause death in favor of outcomes, such as pneumonia or influenza-related pneumonia, and evaluating the extent to which bias is reduced by these and other methods using the 'control' period before influenza season.
Comment in
-
Influenza vaccination in the elderly: current evidence and uncertainties.J Clin Epidemiol. 2009 Jul;62(7):675-6. doi: 10.1016/j.jclinepi.2008.10.006. Epub 2009 Feb 10. J Clin Epidemiol. 2009. PMID: 19211224 No abstract available.
Similar articles
-
Evidence of bias in estimates of influenza vaccine effectiveness in seniors.Int J Epidemiol. 2006 Apr;35(2):337-44. doi: 10.1093/ije/dyi274. Epub 2005 Dec 20. Int J Epidemiol. 2006. PMID: 16368725
-
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors.Int J Epidemiol. 2006 Apr;35(2):345-52. doi: 10.1093/ije/dyi275. Epub 2005 Dec 20. Int J Epidemiol. 2006. PMID: 16368724 Review.
-
Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy.Vaccine. 2009 Oct 23;27(45):6305-11. doi: 10.1016/j.vaccine.2009.07.006. Vaccine. 2009. PMID: 19840665
-
Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents.Vaccine. 2008 Nov 25;26(50):6466-9. doi: 10.1016/j.vaccine.2008.06.038. Epub 2008 Jun 26. Vaccine. 2008. PMID: 18582520
-
Confounding in evaluating the effectiveness of influenza vaccine.Vaccine. 2008 Nov 25;26(50):6459-61. doi: 10.1016/j.vaccine.2008.06.040. Epub 2008 Jun 23. Vaccine. 2008. PMID: 18573295 Review.
Cited by
-
Quantifying and Adjusting for Confounding From Health-Seeking Behavior and Health Care Access in Observational Research.Open Forum Infect Dis. 2024 Oct 23;11(10):ofae598. doi: 10.1093/ofid/ofae598. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39474443 Free PMC article.
-
Confounding and Negative Control Methods in Observational Study of SARS-CoV-2 Vaccine Effectiveness: A Nationwide, Population-Based Danish Health Registry Study.Clin Epidemiol. 2024 Jul 25;16:501-512. doi: 10.2147/CLEP.S468572. eCollection 2024. Clin Epidemiol. 2024. PMID: 39081306 Free PMC article.
-
Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review.Front Public Health. 2024 Apr 19;12:1360556. doi: 10.3389/fpubh.2024.1360556. eCollection 2024. Front Public Health. 2024. PMID: 38706547 Free PMC article. Review.
-
A cross-sectional study from Qatar on the effect of influenza vaccination on the severity of COVID-19.Medicine (Baltimore). 2023 Sep 15;102(37):e35107. doi: 10.1097/MD.0000000000035107. Medicine (Baltimore). 2023. PMID: 37713897 Free PMC article.
-
Effectiveness and durability of a second COVID-19 booster against severe outcomes among older people in Norway: a population-based cohort study comparing mono- and bivalent booster doses.Int J Epidemiol. 2023 Dec 25;52(6):1716-1724. doi: 10.1093/ije/dyad114. Int J Epidemiol. 2023. PMID: 37608733 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
